# BPC-157 versus TB-500 Canonical: https://europeanpeptideshop.com/blog/bpc-157-vs-tb-500-what-the-evidence-shows/ Explore the catalogue and research library. Ordering and shipping have not opened yet. Comparisons · 8 November 2026 · 4 min read · By [European Peptide Shop](https://europeanpeptideshop.com/about/) ### On this page ## Scope of this reference This page concerns the catalogue identity of two separately listed laboratory materials, BPC-157 and TB-500, and the boundaries of what published literature and batch analysis establish about them. It is not a treatment guide, a recommendation, a human-use protocol or evidence that either material is safe or effective in people or animals. ## Two distinct materials, not two names for one thing BPC-157 is a synthetic pentadecapeptide : a chain of fifteen amino acids. Its sequence corresponds to a partial sequence described in the literature on a protein isolated from gastric juice, which is the origin of the "body protection compound" naming. The material supplied is manufactured synthetically and is not extracted from a biological source. It is listed as [BPC-157](https://europeanpeptideshop.com/shop/bpc-157-10mg/). TB-500 is a synthetic peptide corresponding to a short region of thymosin beta-4, a 43-residue protein. TB-500 is a fragment, not the full-length protein, and the two are not interchangeable in either nomenclature or evidence. It is listed as [TB-500](https://europeanpeptideshop.com/shop/tb-500-10mg/). The two therefore differ in length, sequence origin and parent molecule. Materials listed under both names appear in the tissue signalling collection. ## Why the fragment distinction matters when reading studies A large part of the published literature indexed under "thymosin beta-4" concerns the full-length protein, not the fragment supplied as TB-500. Findings reported for a full-length protein cannot be transferred to a shorter synthetic fragment without evidence specific to that fragment. The same caution applies in reverse. This is the single most common error in material descriptions for these two compounds, and it is a question of identity rather than interpretation. ## The blend presentation A combined presentation supplying both materials in one vial is listed as [BPC-157 + TB-500](https://europeanpeptideshop.com/shop/bpc-157-tb-500-10mg/), alongside other research blends. Two points follow from the catalogue facts alone: - A blend is a supply format. Combining two materials in one vial does not generate evidence about the combination. - There is no published literature on this pairing as a pairing. The available literature concerns the individual materials, studied separately, overwhelmingly in non-human models. Statements that attribute properties to the combination are therefore not supported by the evidence base for the components, and we do not make them. ## Reading the evidence by tier Published findings for both materials must be read according to the model that produced them: - In-vitro : assays, cell lines and isolated tissue. Establishes behaviour in that system only. - Animal models : predominantly rodent. Establishes findings in that species under those conditions. - Human data : the tier where claims about people could be grounded, and the tier where the literature on both of these materials is thin to absent. Most of what is published about BPC-157 and TB-500 sits in the first two tiers. Describing a preclinical finding in language that implies a demonstrated human outcome misrepresents the source, regardless of how many sources are cited. ## What analytical documentation establishes A certificate of analysis provides evidence about the particular batch tested: its identity, measured composition and purity by the stated method. It does not establish a biological, therapeutic or physiological outcome, and it does not extend to other batches. For either material, check the full name and SKU, the supplied quantity and physical form, the batch number, whether a report exists for that same batch, and the method, laboratory, date and stated limitations of that report. Available reports are published in the [COA publication status](https://europeanpeptideshop.com/coa/); the guides to [reading a peptide COA](https://europeanpeptideshop.com/blog/how-to-read-peptide-coa/) and [understanding HPLC purity](https://europeanpeptideshop.com/blog/what-hplc-purity-means/) explain what those documents can and cannot show. ## EPS documentation Use the [research catalogue](https://europeanpeptideshop.com/shop/) to check the exact name, labelled amount and format. The [COA library](https://europeanpeptideshop.com/coa/) publishes the original Janoshik reports selected for EPS, retaining the original report client name and any missing batch fields. Literature findings and another supplier's analytical results are not evidence about an EPS batch. ## Laboratory research only Materials listed on this site are supplied for in-vitro laboratory research and are not for use in or on humans or animals. They are not medicines. This article summarises published work and gives no dosing, administration, treatment or in-vivo guidance. Findings from a study apply to the material and conditions of that study, and they say nothing about any product listed here. ## References - [FDA's 2026 BPC-157 briefing document](https://www.fda.gov/media/193343/download) - [2003 rat Achilles-tendon study](https://pubmed.ncbi.nlm.nih.gov/14554208/) - [2011 study of tendon outgrowth and fibroblasts](https://journals.physiology.org/doi/full/10.1152/japplphysiol.00945.2010) - [2014 experiment in rat tendon fibroblasts](https://pubmed.ncbi.nlm.nih.gov/25415472/) - [Esposito et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22962027/) - [Delcourt et al., 2023](https://pubmed.ncbi.nlm.nih.gov/36482504/) - [Malinda et al., 1999](https://pubmed.ncbi.nlm.nih.gov/10469335/) ## Related listings [10 mg](https://europeanpeptideshop.com/shop/bpc-157-10mg/) Tissue repair research ### [BPC-157](https://europeanpeptideshop.com/shop/bpc-157-10mg/) 10 mg · Lyophilised powder Ordering opens later. Prices and availability are not yet published.[Details](https://europeanpeptideshop.com/shop/bpc-157-10mg/) [10 mg](https://europeanpeptideshop.com/shop/tb-500-10mg/) Tissue repair research ### [TB-500](https://europeanpeptideshop.com/shop/tb-500-10mg/) 10 mg · Lyophilised powder Ordering opens later. Prices and availability are not yet published.[Details](https://europeanpeptideshop.com/shop/tb-500-10mg/) ## More articles Documentation · 3 min read ## [What HPLC purity means](https://europeanpeptideshop.com/blog/what-hplc-purity-means/) A chromatographic percentage and the amount in a vial are different measurements. Read the method before comparing the number. 8 November 2026 Compound research · 4 min read ## [BPC-157 research explained](https://europeanpeptideshop.com/blog/bpc-157-research/) A plain-English guide to BPC-157: what the studies measured, what a 10mg vial label means, and how to distinguish evidence from unsupported claims. 8 November 2026 Buying guides · 3 min read ## [BPC-157 vial sizes and prices](https://europeanpeptideshop.com/blog/bpc-157-vial-prices/) Compare bpc-157 vial sizes and prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes. 8 November 2026